Tag: home infusion therapy

BANNOCKBURN, Ill. – Option Care Health saw double-digit growth in revenues as the company took advantage of its technology platform to respond to the disruption caused by the COVID-19 pandemic, said CEO John Rademacher on a recent earnings call.  Option Care Health reported net revenues of $804.7 million for the fourth quarter of 2020, an increase of 11.6% compared to the same quarter in 2019.  “Our ability to quickly pivot and utilize our technology...

BANNOCKBURN, Ill. – Option Care Health has agreed to sell 12 million shares of the company’s common stock at $20 per share in an underwritten public offering. The selling stockholder, an affiliate of Madison Dearborn Partners, also granted the underwriter a 30-day option to purchase up to 1.8 million additional shares of common stock. The offering is expected to close today, March 17. This sale of shares represents approximately 6.7% of the current shares outstanding. Option Care...

FRISCO, Texas - Soleo Health has been named by AscellaHealth, a specialty pharmacy benefit manager, as an exclusive provider for the care and management of its members with hemophilia. AscellaHealth has a broad-based Hemophilia Management Program that includes an expanded budget that allocates significant resources for pharmacy costs. As a preferred provider, and through its SoleMetrics proprietary clinical outcomes program, Soleo Health will support AscellaHealth in its efforts to reduce costs and...

BANNOCKBURN, Ill. - Option Care Health has been chosen to participate in a limited distribution network for VILTEPSO (viltolarsen) for patients with Duchenne Muscular Dystrophy who are amenable to exon 53 skipping therapy. Viltepso is among a growing number of chronic infusion therapies for neuromuscular disorders that Option Care Health is able to deliver to patients at home or in one of the company's more than 125 ambulatory infusion suites across the country. “Our demonstrated track record...

BANNOCKBURN, Ill. - Option Care Health saw a decline in new patient referrals during the second quarter of 2020 due to COVID-19, but that was offset by growth in its chronic care business, says CEO John Rademacher.“Patient transfers onto service with us from other sites of care drove low double-digit growth in the second quarter,” said Rademacher during a conference call to discuss the company's recent financial results. “We continue to work with referral sources and payers to identify...

WASHINGTON - CMS continues to dig in its heels on the new home infusion benefit, leaving stakeholders considering a legislative fix.In a proposed home health rule for 2021 released on June 25, the agency continues to limit reimbursement to only those days when a nurse is in the home.“At this point, there's some questions as to what they believe exists within their regulatory authority,” said Shea McCarthy, director of legislative affairs for the National Home Infusion Association. “A...

BANNOCKBURN, Ill. - While much of the current focus around the coronavirus pandemic focuses on respiratory complications, home infusion providers have been busy doing their part to help hospitals “clear the decks” and free up hospital beds for COVID-19 patients, says Harriet Booker, COO at Option Care Health.“We can work with them on a host of disease states to determine if the patient is suitable for home infusion,” she said, “and how quickly and safely we can get them...

BANNOCKBURN, Ill. - Option Care Health has expanded its use of Wolters Kluwer's Simplifi 797, its web-based compounding compliance solution. Option Care Health's expanded use of Wolters Kluwer's solutions will allow it to standardize training and promote nationwide adoption of best practices to ensure staff and patient safety, and maximize efficiency. “Safety and quality are at the forefront of everything we do,” said Don Filibeck, vice president of pharmacy. “Wolters Kluwer is...

ELYRIA, Ohio - Invacare reported net sales of $218.4 million in the first quarter, a 2.2% decrease compared to the same period last year.It reported $87 million in net sales for North America, specifically, about a 1% increase, driven by increased respiratory and mobility and seating product sales.The company saw a 4% increase in mobility and seating product sales, driven by a 16% increase in power wheelchairs and offset by a decline in manual mobility product sales.Gross profit was $63 million for...

CERRITOS, Calif. - KabaFusion plans to expand its focus beyond IVIG to other infusion therapies with its recent acquisition of Lincare's home infusion business, says founder and CEO Dr. Sohail Masood.The deal, announced in early March, also expands the company's footprint, adding specialty pharmacies in 11 markets where KabaFusion has no presence, for a total of 28 locations in 16 states.“We started KabaFusion in 2010 primarily focusing on IVIG therapy, but Lincare gives us a chance to expand...